The rising aging male population in China is seriously driving demand in the China Benign Prostatic Hyperplasia Treatment Market. Benign Prostatic Hyperplasia (BPH) is extremely common among men over 50, and with China’s demographic shift toward an older population, diagnosis rates are climbing quickly. Urban hospitals and urology clinics are seeing more patients reporting urinary...